Francis Plat

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial

Stevo Julius, Sverre E. Kjeldsen, Michael A. Weber et al. · The Lancet · 2004 · 2.5K citations

Medicine, Pharmacology, Pharmacotherapy +13

Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial

Michael A. Weber, Stevo Julius, Sverre E. Kjeldsen et al. · The Lancet · 2004 · 592 citations

Medicine, Cardiology, Pharmacotherapy +11

Changes in ventricular remodelling and clinical status during the year following a single administration of stromal cell-derived factor-1 non-viral gene therapy in chronic ischaemic heart failure patients: the STOP-HF randomized Phase II trial

Eugene S. Chung, Leslie W. Miller, Amit N. Patel et al. · European Heart Journal · 2015 · 175 citations · Full text

Medicine, Cardiology, Pharmacotherapy +14

Outcomes in subgroups of hypertensive patients treated with regimens based on valsartan and amlodipine: an analysis of findings from the VALUE trial

Alberto Zanchetti, Stevo Julius, Sverre E. Kjeldsen et al. · Journal of Hypertension · 2006 · 174 citations

Medicine, Cardiology, Pharmacotherapy +17

6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial

Xavier Pivot, Gilles Romieu, Marc Debled et al. · The Lancet · 2019 · 128 citations

Medicine, Oncology, Breast Oncology +9